COMMUNIQUÉS West-GlobeNewswire

Navamedic ASA: Second quarter results 2017
28/07/2017
Oslo, 28 July 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 89.7 million in the second quarter of 2017 (NOK 66.7 million in Q2 2016), representing a growth of 34.4%, following the successful ramp-up of the [...]
Essilor - Communiqué : Une performance résiliente au premier semestre
28/07/2017
Une performance résiliente au premier semestre Version PDF du communiqué Hausse de 9,1 % du chiffre d'affaires, dont 6,9 % hors change Meilleure dynamique en Amérique du Nord, bonne performance de l'Europe Pays à forte [...]
Essilor - News Release: Resilient First Half
28/07/2017
Resilient First Half PDF Version of the news release Revenue growth of 9.1% and 6.9% in constant currency Improving momentum in North America, good performance in Europe Fast-Growing Markets impacted by a decline in [...]
Essilor : Mise à disposition du rapport financier semestriel 2017
28/07/2017
Mise à disposition du rapport financier semestriel 2017 Charenton-le-Pont, France (le 28 juillet 2017 - 6h30) - Essilor International publie ce matin son rapport financier semestriel 2017. Ce document comprend les [...]
Essilor: Publication of the 2017 Interim Financial Report
28/07/2017
Publication of the 2017 Interim Financial Report Charenton-le-Pont, France (July 28, 2017 - 6:30 am) - The Essilor International 2017 Interim Financial Report is being published today. The report comprises the interim [...]
Solid financials support R&D progress
27/07/2017
Solid financials support R&D progress This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are [...]
Servier licenses GLPG1972 in osteoarthritis from Galapagos
27/07/2017
Servier licenses GLPG1972 in osteoarthritis This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are [...]
Novo Nordisk A/S: Victoza® has been approved in the EU as the only GLP-1 with a label to include prevention of cardiovascular events
27/07/2017
Bagsværd, Denmark, 27 July 2017 - The European Commission has approved an update to the Victoza ® (liraglutide) EU label that expands the indication to reflect both improving blood sugar and cardiovascular (CV) events [...]
GUERBET : Chiffre d'affaires au 30 juin 2017
27/07/2017
397,7 M€ à taux de change constant : +5,6% Progression satisfaisante de l'activité Villepinte, le 27 juillet 2017 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie [...]
GUERBET : Revenue at June 30, 2017
27/07/2017
€397.7 million at constant exchange rates, up 5.6% Satisfactory activity growth Villepinte, July 27, 2017 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is [...]
Diaxonhit : Chiffre d'Affaires du 1er semestre 2017 en croissance de 31% à 19,6 millions d'euros
27/07/2017
DIAXONHIT : chiffre d'affaires du 1er semestre 2017 en croissance de 31% Chiffre d'affaires semestriel consolidé en forte progression de +31% à 19,6 millions d'euros, en raison de l'acquisition d'Eurobio le 30 mars 2017 [...]
Oriola Corporation - Repurchase of own shares on 27 July 2017
27/07/2017
ORIOLA CORPORATION STOCK EXCHANGE RELEASE 27 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 27 July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 11 209 Average price/share, EUR 3,5995 Total [...]
Ossur Hf : Insider Trading
27/07/2017
Announcement Össur hf. No.53/2017 Reykjavík, 27 July 2017 Auðkenni útgefanda/Trade ticker: OSSR Nafn útgefanda/Issuer: Össur hf. Dagsetning tilkynningar/Date of announcement: 27 July 2017 Nafn fruminnherja/Name primary [...]
Minerva Neurosciences to Report Second Quarter 2017 Financial Results and Business Updates on August 3, 2017
27/07/2017
Management to host conference call WALTHAM, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat [...]
Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year
27/07/2017
Company announces Japanese reimbursement for Impella® heart pumps and raises lower end of FY 2018 revenue guidance DANVERS, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of [...]
Arix Bioscience co-leads $29 million Series A financing for PreciThera, Inc.
27/07/2017
Arix Bioscience co-leads $29 million Series A financing for PreciThera, Inc. Funding to develop novel biologics targeting orphan bone diseases into clinical trials LONDON, 27 July 2017: Arix Bioscience plc (LSE: ARIX [...]
RECORDATI: VERY GOOD RESULTS IN THE FIRST HALF 2017. CONTINUED GROWTH IN SALES +10.7%, OPERATING INCOME +19.4%, NET INCOME +19.8%
27/07/2017
Consolidated revenues € 650.9 million, +10.7%. EBITDA (1) € 224.0 million, +19.1% Operating income € 203.2 million, +19.4%. Net income € 147.0 million, +19.8%. Net financial position (2) : net debt of € 356.3 million. [...]
William Demant Holding A/S: Major shareholder announcement concerning Canada Pension Plan Investment Board
27/07/2017
Company announcement no 2017-08 27 July 2017 Major shareholder announcement concerning Canada Pension Plan Investment Board pursuant to section 29 of the Danish Securities Trading Act Pursuant to section 29 of the [...]
Bavarian Nordic Announces Additional Details Regarding the Issue of Shares to Johnson & Johnson Innovation - JJDC, Inc.
27/07/2017
COPENHAGEN, Denmark, July 27, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces additional details regarding the issue of shares to Johnson & Johnson Innovation - JJDC, Inc. ("J&J") in connection with [...]

Pages